ID: ALA1794797

Max Phase: Preclinical

Molecular Formula: C6H13NO3

Molecular Weight: 147.17

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@H](O)[C@H]1NC[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C6H13NO3/c1-3(8)5-6(10)4(9)2-7-5/h3-10H,2H2,1H3/t3-,4-,5-,6-/m1/s1

Standard InChI Key:  HVRWFMCLXNLOCH-KVTDHHQDSA-N

Associated Targets(non-human)

Alpha-mannosidase 2C1 19 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 147.17Molecular Weight (Monoisotopic): 147.0895AlogP: -1.94#Rotatable Bonds: 1
Polar Surface Area: 72.72Molecular Species: BASEHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.31CX Basic pKa: 9.52CX LogP: -1.84CX LogD: -3.93
Aromatic Rings: 0Heavy Atoms: 10QED Weighted: 0.35Np Likeness Score: 2.37

References

1. Winkler DA, Holan G..  (1989)  Design of potential anti-HIV agents. 1. Mannosidase inhibitors.,  32  (9): [PMID:2504921] [10.1021/jm00129a011]

Source